Heartflow (NASDAQ:HTFL) Stock: Insider John C.M. Farquhar Sells 38,900 Shares

Heartflow, Inc. (NASDAQ:HTFL) CEO John Farquhar sold 38,900 shares of the firm’s stock in a transaction that occurred on Tuesday, November 10th. The shares were sold at an average price of $55.74, for a total transaction of $2,168,286.00. Following the completion of the sale, the chief executive officer directly owned 251,983 shares in the company, valued at approximately $14,045,532.42. This trade represents a 13.37% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

John C.M. Farquhar also recently made the following trade(s):

• On Monday, October 12th, John Farquhar sold 38,900 shares of Heartflow stock. The stock was sold at an average price of $49.57, for a total transaction of $1,928,273.00.
• On Friday, September 11th, John Farquhar sold 3,890 shares of Heartflow stock. The stock was sold at an average price of $50.00, for a total transaction of $194,500.00.
• On Thursday, September 10th, John Farquhar sold 35,010 shares of Heartflow stock. The stock was sold at an average price of $46.42, for a total transaction of $1,625,164.20.
• On Friday, August 21st, John Farquhar sold 27,230 shares of Heartflow stock. The shares were sold at an average price of $50.00, for a total transaction of $1,361,500.00.
• On Tuesday, August 18th, John Farquhar sold 32,676 shares of Heartflow stock. The shares were sold at an average price of $45.00, for a total transaction of $1,470,420.00.
• On Friday, August 14th, John Farquhar sold 15,560 shares of Heartflow stock. The shares were sold at an average price of $39.06, for a total transaction of $607,773.60.

Heartflow Stock Up 5.9%

Heartflow stock opened at $59.10 on Thursday. The company has a fifty day simple moving average of $51.73 and a 200-day simple moving average of $35.00. Heartflow, Inc. has a 12-month low of $20.13 and a 12-month high of $60.66.

Heartflow (NASDAQ:HTFL) last posted its earnings results on Thursday, August 13th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%. The firm had revenue of $64.08 million for the quarter. Heartflow’s revenue was up 47.7% compared to the same quarter last year. On average, equities research analysts expect that Heartflow, Inc. will post -0.75 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Heartflow

Several institutional investors have recently bought and sold shares of the company. XXEC Inc. purchased a new stake in Heartflow in the 2nd quarter valued at approximately $2,524,764,000. BlackRock Inc. purchased a new stake in Heartflow during the second quarter worth about $152,502,000. Bamco Inc. NY purchased a new stake in Heartflow during the second quarter worth about $94,625,000. Jupiter Topco LLC purchased a new stake in Heartflow during the second quarter worth about $70,983,000. Finally, Janus Henderson Group PLC grew its position in Heartflow by 152.0% during the first quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock worth $53,063,000 after buying an additional 1,315,416 shares during the period.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the company. Wells Fargo & Company upped their price objective on Heartflow from $37.00 to $39.00 and gave the stock an “overweight” rating in a research report on Friday, August 14th. Morgan Stanley boosted their target price on Heartflow from $35.00 to $40.00 and gave the stock an “equal weight” rating in a research note on Friday, August 14th. Stifel Nicolaus increased their target price on shares of Heartflow from $40.00 to $45.00 and gave the company a “buy” rating in a research report on Friday, August 14th. Benchmark reiterated a “buy” rating on shares of Heartflow in a research note on Friday, August 14th. Finally, Wall Street Zen cut shares of Heartflow from a “buy” rating to a “hold” rating in a research report on Saturday, November 7th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Heartflow has an average rating of “Moderate Buy” and an average price target of $48.62.

About Heartflow

HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.